Rachel Kroe-Barrett Department of Biotherapeutics Discovery, Immune Modulation and Biotherapeutics Discovery Boehringer Ingelheim Pharmaceuticals, Inc. Biography Publications Institution JoVE Articles Rachel Kroe-Barrett has not added a biography. If you are Rachel Kroe-Barrett and would like to personalize this page please email our Author Liaison for assistance. Publications Dataset of the Binding Kinetic Rate Constants of Anti-PCSK9 Antibodies Obtained Using the Biacore T100, ProteOn XPR36, Octet RED384, and IBIS MX96 Biosensor Platforms Data in Brief. Sep, 2016 | Pubmed ID: 27547794 Comparison of Biosensor Platforms in the Evaluation of High Affinity Antibody-antigen Binding Kinetics Analytical Biochemistry. Sep, 2016 | Pubmed ID: 27365220 Efficient Qualitative and Quantitative Determination of Antigen-induced Immune Responses The Journal of Biological Chemistry. Jul, 2016 | Pubmed ID: 27288409 Weak Protein Interactions and PH- and Temperature-dependent Aggregation of Human Fc1 MAbs. 2015 | Pubmed ID: 26267255 Selective Targeting of the IL23 Pathway: Generation and Characterization of a Novel High-affinity Humanized Anti-IL23A Antibody MAbs. 2015 | Pubmed ID: 25905918 Competing Aggregation Pathways for Monoclonal Antibodies FEBS Letters. Mar, 2014 | Pubmed ID: 24530501 Fully Human Antibodies Against the Protease-Activated Receptor-2 (PAR-2) with Anti-inflammatory Activity Human Antibodies. 2011 | Pubmed ID: 22129678 Dört Biyosensör Platformları kullanma Yüksek yakınlık Antikor-antijen Cilt Kinetiklerinin Belirlenmesi Danlin Yang1, Ajit Singh2, Helen Wu1, Rachel Kroe-Barrett1 1Department of Biotherapeutics Discovery, Immune Modulation and Biotherapeutics Discovery, Boehringer Ingelheim Pharmaceuticals, Inc., 2The Fu Foundation School of Engineering and Applied Science, Columbia University JoVE 55659 Biochemistry
Dört Biyosensör Platformları kullanma Yüksek yakınlık Antikor-antijen Cilt Kinetiklerinin Belirlenmesi Danlin Yang1, Ajit Singh2, Helen Wu1, Rachel Kroe-Barrett1 1Department of Biotherapeutics Discovery, Immune Modulation and Biotherapeutics Discovery, Boehringer Ingelheim Pharmaceuticals, Inc., 2The Fu Foundation School of Engineering and Applied Science, Columbia University JoVE 55659 Biochemistry
